These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 176358)

  • 1. Natural estrogen and anti-thrombin III activity in postmenopausal women.
    Notelovitz M; Greig HB
    J Reprod Med; 1976 Feb; 16(2):87-90. PubMed ID: 176358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of various estrogen treatment schedules on antithrombin III levels.
    Ambrus JL; Ambrus CM; Lillie MA; Browne BJ; Hanson FW; Niswander K; Witul M; Jung OS; Bartfay-Szabo A
    Res Commun Chem Pathol Pharmacol; 1976 Jul; 14(3):543-9. PubMed ID: 959656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oestrogen containing oral contraceptives and antithrombin III activity.
    Rákóczi I; Nagy I; Szigetvári I; Losonczy H; Hadnagy J; Gáti I
    Acta Physiol Acad Sci Hung; 1974; 45(3-4):281-6. PubMed ID: 4471272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of two estrogen preparations (a combined contraceptive pill versus conjugated estrogen cream) intravaginally to treat urogenital symptoms in postmenopausal Thai women: a comparative study.
    Chompootaweep S; Nunthapisud P; Trivijitsilp P; Sentrakul P; Dusitsin N
    Clin Pharmacol Ther; 1998 Aug; 64(2):204-10. PubMed ID: 9728901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of estrogen-progestin hormonal replacement therapy on plasma antithrombin III of postmenopausal women.
    Bonduki CE; Lourenço DM; Baracat E; Haidar M; Noguti MA; da Motta EL; Lima GR
    Acta Obstet Gynecol Scand; 1998 Mar; 77(3):330-3. PubMed ID: 9539282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of estrogens as a risk factor for stroke in postmenopausal women.
    Rosenberg SH; Fausone V; Clark R
    West J Med; 1980 Oct; 133(4):292-6. PubMed ID: 7347044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogens, progestogens and endometrial cancer.
    Gambrell RD
    J Reprod Med; 1977 Jun; 18(6):301-6. PubMed ID: 196079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depo-medroxyprogesterone acetate compared with conjugated estrogens for the treatment of postmenopausal women.
    Lobo RA; McCormick W; Singer F; Roy S
    Obstet Gynecol; 1984 Jan; 63(1):1-5. PubMed ID: 6318170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Better oral reading and short-term memory in midlife, postmenopausal women taking estrogen.
    Shaywitz SE; Naftolin F; Zelterman D; Marchione KE; Holahan JM; Palter SF; Shaywitz BA
    Menopause; 2003; 10(5):420-6. PubMed ID: 14501603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of estrogens and estrogen-induced effects on nonreproductive organs and systems.
    Gorrill MJ; Marshall JR
    J Reprod Med; 1986 Sep; 31(9 Suppl):842-7. PubMed ID: 3772905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of menopause and hormone therapy on erythrocyte deformability.
    Sakashita T; Nobuzane T; Miyoshi H; Fujiwara H; Kudo Y
    Menopause; 2009; 16(3):555-8. PubMed ID: 19169165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Types of estrogen and delivery systems.
    Whitehead MI
    Postgrad Med; 1989 Apr; Spec No():78-83; discussion 89-90. PubMed ID: 2542912
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormonal treatment of the menopause and vascular pathology].
    Rozenbaum H
    J Mal Vasc; 1984; 9 Suppl A():32-4. PubMed ID: 6330256
    [No Abstract]   [Full Text] [Related]  

  • 14. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.
    Light KC; Grewen KM; Amico JA; Brownley KA; West SG; Hinderliter AL; Girdler SS
    Horm Behav; 2005 May; 47(5):540-8. PubMed ID: 15811355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H; Heytmanek H; Kurz C; Metka M
    Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation activation following estrogen administration to postmenopausal women.
    Caine YG; Bauer KA; Barzegar S; ten Cate H; Sacks FM; Walsh BW; Schiff I; Rosenberg RD
    Thromb Haemost; 1992 Oct; 68(4):392-5. PubMed ID: 1333098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antithrombin 3 changes in women using oral contraceptives].
    Conard J; Salomon Y; Samama M
    Pathol Biol (Paris); 1974 Jan; 22(1):77-80. PubMed ID: 4592416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of conjugated estrogens on coagulability in menopausal women.
    Stangel JJ; Innerfield I; Reyniak JV; Stone ML
    Obstet Gynecol; 1977 Mar; 49(3):314-6. PubMed ID: 190571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncontraceptive estrogen use and cardiovascular disease.
    Bush TL; Barrett-Connor E
    Epidemiol Rev; 1985; 7():89-104. PubMed ID: 2996919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.